AMPE News and Press, Ampio Pharmaceuticals Inc. From 12/14/20

AnPac Bio-Medical Science (ANPC) +99% as company makes significant progress in detecting pre-cancer diseases.Arvinas (ARVN) +74% after releasing interim clinical data of PROTAC® protein degraders.Veru (VERU) +57% on positive phase 2 clinical trial results for Enobosarm.Syn...

Biotech Penny Stocks To Watch In December, 2020 Are you paying attention to biotech stocks; penny stocks in particular? If you haven’t looked at the sector yet, then it might be time to. Let me be clear, I’m not talking about the broader healthcare industry. Biotech st...

vTv Therapeutics VTVT +128% as MacAndrews & Forbes buys 625K shares.Sonoma Pharmaceuticals SNOA +122% on Crown Laboratories partnership.FAT Brands FAT +60% on plan to merge with controlling shareholder Fog Cutter Capital.Lexicon Pharmaceuticals LXRX +38%...

Ampio Pharmaceuticals ([[AMPE]] -5.9%) has entered into two collaborative research agreements to explore new clinical indications for its immunomodulatory drug, Ampion.Currently in clinical trials for treatment of inflammation due to osteoarthritis and COVID-19 related acute respiratory distr...

Ampio Enters into Collaborative Research Agreements to Explore Additional Clinical Indications for its Immunomodulatory Drug, Ampion ENGLEWOOD, Colo. , Dec. 10, 2020 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company...

Palm Beach, FL –December 9, 2020 – In the breast cancer therapy market, the rise in the healthcare awareness among individual’s disease and treatment, early detection of the cancer, better surgical and medical treatment, R&D initiatives, and technological advancemen...

Intec Pharma (NTEC) +111% after research pact with UK-based GW Pharma.Recon Technology (RCON) +102%.Francesca's Holdings (FRAN) +99% after receiving court approval of first day motions to support ongoing operations.ZW Data Action Technologies (CNET) +101% after opening its firs...

Ampio Pharmaceuticals, Inc. to Host its Annual Meeting on December 12, 2020 ENGLEWOOD, Colo., Dec. 8, 2020 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalen...

Curis CRIS +199% on encouraging CA-4948 data in leukemia.NeuroMetrix (NURO) +84%.Stitch Fix SFIX +39% on Q1 results.Lexicon Pharmaceuticals (LXRX) +31%.Cancer Genetics (CGIX) +28%.Smartsheet SMAR +18% on Q3 results.Tarena TEDU +18% on founder's going pr...

Ampio Pharmaceuticals ([[AMPE]] +6.1%) says that its Phase I trial of inhaled Ampion (AP-014) in COVID-19 patients proceeded to full open enrollment following clearance by the Safety Monitoring Committee ((SMC)), which found Ampion to be safe and well-tolerated after revie...